Nancy Ness

Rapid Diagnostek, Inc. develops sensor appropriate for detecting bacteria, viruses, spores and disease biomarkers. Its products include test cartridge, instrument and assays. The company was founded in 1986 by Richard A. Van Deusen and is headquartered in Plymouth, MN.

Interrad Medical, Inc. develops, manufactures and markets medical devices. Its products include securacath, securement comparison, patents and publication. The company was founded by Michael S. Rosenberg in 2004 and is headquartered in Plymouth, MN.

Anulex Technologies, Inc. develops medical technologies. It focuses on the research and development of medical technologies to preserve and repair soft tissue of the spine for patients undergoing a surgical procedure to remove a herniated disc. The company was founded in 2001 by Matthew M. Burns and is headquartered in Minneapolis, MN.

Part of Hyphen Solutions LLC, HomeStyles Publishing & Marketing, Inc. provides pre-drawn home plans for builders and consumers on the Internet. The company is based in St. Paul, MN. HomeStyles Publishing & Marketing was acquired by BuildNet, Inc. on September 06, 2000.

Northwest Airlines, Inc. provided commercial transportation services for passengers and cargo. The firm owned and operated domestic and international route networks and serves more than 750 cities in 120 countries. The company was founded in 1926 and was headquartered in Minneapolis, MN.

K Spine, Inc. develops implantable medical devices for the treatment of spine disorders. It offers products for correcting an abnormal curvature of the spine. The company was founded by Danny Sachs and is headquartered in Minneapolis, MN.

CoAxiaTM was a development stage, private, venture-backed medical device company in clinical trials with an innovative, catheter-based therapy for the treatment of cerebral ischemia, most notably: ischemic stroke. CoAxia's business focus was demonstrating the safety and efficacy of its NeuroFlo™ catheter and making it a standard treatment option hundreds of thousands of stroke patients worldwide. In addition, CoAxia was in limited distribution of NeuroFlo to treat cerebral vasospasm, under an HDE market approval from the FDA. CoAxia holds several key patents on the concept and implementation of cerebral perfusion augmentation as well as numerous other patents relevant to various vascular disorders. CoAxia was founded in 1999 by Denise Barbut MD.